Corporate Valuations - News Japan s Takeda to acquire US cancer drugmaker for over $ 5 bn



corporatevaluations.in : news

Japan s Takeda to acquire US cancer drugmaker for over $ 5 bn


Date: 12-January-2017

Japan s Takeda Pharmaceutical Co flagged its appetite for fresh acquisitions to bolster its drug portfolio after agreeing on Monday to acquire cancer drug maker Ariad Pharmaceuticals in a $5.20 billion deal. Takeda will pay $24 in cash for each Ariad share, a premium of nearly 75 percent to the stock s $13.74 closing price.Takeda predicts annual sales from Brigatinib (Ariad pharma), which the US Food and Drug Administration is expected to decide on by April, could exceed $1 billion. At the end of its last business year that ended on March 31, Takeda had 438 billion yen ($3.79 billion) in cash and cash equivalents.

 
 
 
Our Offerings